Filed: 11/14/2025ACC: 0001104659-25-112697
📋 What this filing means
BELLEVUE GROUP AG filed this quarterly 13F‑HR report disclosing 148 equity positions with a total reported market value of $4.81B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
148
Positions
$4.81B
Total AUM (reported)
88.08M
Total Shares
Allocation by class
COM$3.76B78.2%
SPONSORED ADR$411.05M8.5%
COM NEW$259.12M5.4%
SHS$110.62M2.3%
ADS$101.61M2.1%
SPONSORED ADS$35.14M0.7%
COMMON STOCK$34.78M0.7%
Portfolio Concentration
Top 3$1.07B22.3%
4–10$1.33B27.7%
11–25$1.29B26.8%
Rest$1.12B23.3%
Top 3 weight
22.3%
Top 10 weight
49.9%
Voting Authority Distribution
Total shares with voting rights: 88.08M
Sole
Full voting authority
88.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other148
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings148
Rows:
IONIS PHARMACEUTICALS INC
DFNDShares6.24M
TypeSH
Market value$408.51M
8.49%
Sole
6.24M
Shared
0.00
None
0.00
ARGENX SE
DFNDShares546.33K
TypeSH
Market value$402.95M
8.37%
Sole
546.33K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
DFNDShares5.57M
TypeSH
Market value$260.30M
5.41%
Sole
5.57M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
DFNDShares1.76M
TypeSH
Market value$247.50M
5.14%
Sole
1.76M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
DFNDShares446.52K
TypeSH
Market value$203.61M
4.23%
Sole
446.52K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
DFNDShares505.81K
TypeSH
Market value$198.09M
4.12%
Sole
505.81K
Shared
0.00
None
0.00
ABBOTT LABS
DFNDShares1.48M
TypeSH
Market value$198.04M
4.11%
Sole
1.48M
Shared
0.00
None
0.00
STRYKER CORPORATION
DFNDShares451.10K
TypeSH
Market value$166.76M
3.46%
Sole
451.10K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
DFNDShares1.66M
TypeSH
Market value$162.05M
3.37%
Sole
1.66M
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
DFNDShares348.63K
TypeSH
Market value$155.92M
3.24%
Sole
348.63K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
DFNDShares3.71M
TypeSH
Market value$149.11M
3.10%
Sole
3.71M
Shared
0.00
None
0.00
INCYTE CORP
DFNDShares1.44M
TypeSH
Market value$122.18M
2.54%
Sole
1.44M
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
DFNDShares3.24M
TypeSH
Market value$120.83M
2.51%
Sole
3.24M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
DFNDShares2.39M
TypeSH
Market value$113.44M
2.36%
Sole
2.39M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
DFNDShares2.80M
TypeSH
Market value$101.61M
2.11%
Sole
2.80M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
DFNDShares2.15M
TypeSH
Market value$93.80M
1.95%
Sole
2.15M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
DFNDShares3.56M
TypeSH
Market value$92.04M
1.91%
Sole
3.56M
Shared
0.00
None
0.00
MEDTRONIC PLC
DFNDShares759.86K
TypeSH
Market value$72.37M
1.50%
Sole
759.86K
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
DFNDShares2.89M
TypeSH
Market value$70.12M
1.46%
Sole
2.89M
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
DFNDShares896.63K
TypeSH
Market value$69.73M
1.45%
Sole
896.63K
Shared
0.00
None
0.00
INSULET CORP
DFNDShares212K
TypeSH
Market value$65.45M
1.36%
Sole
212K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
DFNDShares170.06K
TypeSH
Market value$58.72M
1.22%
Sole
170.06K
Shared
0.00
None
0.00
BECTON DICKINSON & CO
DFNDShares296.89K
TypeSH
Market value$55.57M
1.15%
Sole
296.89K
Shared
0.00
None
0.00
DEXCOM INC
DFNDShares786.12K
TypeSH
Market value$52.90M
1.10%
Sole
786.12K
Shared
0.00
None
0.00
THERMO FISHER SCIENTIFIC INC
DFNDShares106.19K
TypeSH
Market value$51.50M
1.07%
Sole
106.19K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IONIS PHARMACEUTICALS INCDFND | COM | 6.24M | SH | $408.51M 8.49% | 6.24M | 0.00 | 0.00 |
ARGENX SEDFND | SPONSORED ADR | 546.33K | SH | $402.95M 8.37% | 546.33K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCDFND | COM | 5.57M | SH | $260.30M 5.41% | 5.57M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCDFND | COM | 1.76M | SH | $247.50M 5.14% | 1.76M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCDFND | COM | 446.52K | SH | $203.61M 4.23% | 446.52K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCDFND | COM | 505.81K | SH | $198.09M 4.12% | 505.81K | 0.00 | 0.00 |
ABBOTT LABSDFND | COM | 1.48M | SH | $198.04M 4.11% | 1.48M | 0.00 | 0.00 |
STRYKER CORPORATIONDFND | COM | 451.10K | SH | $166.76M 3.46% | 451.10K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPDFND | COM | 1.66M | SH | $162.05M 3.37% | 1.66M | 0.00 | 0.00 |
INTUITIVE SURGICAL INCDFND | COM NEW | 348.63K | SH | $155.92M 3.24% | 348.63K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCDFND | COM | 3.71M | SH | $149.11M 3.10% | 3.71M | 0.00 | 0.00 |
INCYTE CORPDFND | COM | 1.44M | SH | $122.18M 2.54% | 1.44M | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPDFND | COM | 3.24M | SH | $120.83M 2.51% | 3.24M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCDFND | COM | 2.39M | SH | $113.44M 2.36% | 2.39M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCDFND | ADS | 2.80M | SH | $101.61M 2.11% | 2.80M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCDFND | COM | 2.15M | SH | $93.80M 1.95% | 2.15M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWDFND | COM NEW | 3.56M | SH | $92.04M 1.91% | 3.56M | 0.00 | 0.00 |
MEDTRONIC PLCDFND | SHS | 759.86K | SH | $72.37M 1.50% | 759.86K | 0.00 | 0.00 |
BEAM THERAPEUTICS INCDFND | COM | 2.89M | SH | $70.12M 1.46% | 2.89M | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPDFND | COM | 896.63K | SH | $69.73M 1.45% | 896.63K | 0.00 | 0.00 |
INSULET CORPDFND | COM | 212K | SH | $65.45M 1.36% | 212K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCDFND | COM | 170.06K | SH | $58.72M 1.22% | 170.06K | 0.00 | 0.00 |
BECTON DICKINSON & CODFND | COM | 296.89K | SH | $55.57M 1.15% | 296.89K | 0.00 | 0.00 |
DEXCOM INCDFND | COM | 786.12K | SH | $52.90M 1.10% | 786.12K | 0.00 | 0.00 |
THERMO FISHER SCIENTIFIC INCDFND | COM | 106.19K | SH | $51.50M 1.07% | 106.19K | 0.00 | 0.00 |
Page 1 of 6
…